Show Summary Details
Page of

Treatment of Cutaneous Hemangiomas 

Treatment of Cutaneous Hemangiomas
Chapter:
Treatment of Cutaneous Hemangiomas
Author(s):

John B. Mulliken

DOI:
10.1093/med/9780195145052.003.0006
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 10 April 2020

Physicians, usually those of a surgical disposition, have been resourceful in responding to the call of a rapidly growing hemangioma—do something—try anything. In the past, these tumors were assailed by caustics, cautery, injection of irritating solutions and irradiation. Hemangioma’s natural history of spontaneous regression only came to be appreciated in the middle 20th century. Today, pharmacologic therapy is preferred; however, there is vigorous debate over the traditional choice of corticosteroid versus the newcomer, the beta-blockers. There is still a role for surgical intervention in the proliferative, involuting, and involuted phases. Operating on hemangioma at any stage is a surgical subspeciality that requires understanding in the third dimension and awareness of the fourth dimension.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.